GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-0.03%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$207M
AUM Growth
+$207M
Cap. Flow
-$27.9M
Cap. Flow %
-13.5%
Top 10 Hldgs %
43.1%
Holding
75
New
17
Increased
13
Reduced
15
Closed
14

Top Buys

1
KRYS icon
Krystal Biotech
KRYS
$6.96M
2
IMVT icon
Immunovant
IMVT
$4.99M
3
TARS icon
Tarsus Pharmaceuticals
TARS
$4.44M
4
TSHA icon
Taysha Gene Therapies
TSHA
$4.19M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.13M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$16.4M
2
AKRO icon
Akero Therapeutics
AKRO
$12.4M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$8.67M
4
PCVX icon
Vaxcyte
PCVX
$7.14M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
$6.13M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMGN
26
DELISTED
Immunogen Inc
IMGN
$2.78M 0.91%
175,000
+75,000
+75% +$1.19M
GPCR icon
27
Structure Therapeutics
GPCR
$1.14B
$2.77M 0.91%
+55,000
New +$2.77M
JBIO
28
Jade Biosciences, Inc. Common Stock
JBIO
$245M
$2.73M 0.9%
201,197
– –
MOR
29
DELISTED
MorphoSys AG American Depositary Shares
MOR
$2.69M 0.88%
+400,000
New +$2.69M
CYTK icon
30
Cytokinetics
CYTK
$5.98B
$2.65M 0.87%
+90,000
New +$2.65M
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.61M 0.86%
60,000
-140,000
-70% -$6.1M
EYPT icon
32
EyePoint Pharmaceuticals
EYPT
$827M
$2.6M 0.85%
+325,000
New +$2.6M
VKTX icon
33
Viking Therapeutics
VKTX
$3.02B
$2.49M 0.82%
225,000
-425,000
-65% -$4.7M
ATXS icon
34
Astria Therapeutics
ATXS
$394M
$2.24M 0.74%
300,000
-173
-0.1% -$1.29K
FOLD icon
35
Amicus Therapeutics
FOLD
$2.42B
$2.13M 0.7%
175,000
-25,000
-13% -$304K
KRTX
36
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.11M 0.7%
12,500
– –
SLRN
37
DELISTED
ACELYRIN
SLRN
$2.03M 0.67%
+200,000
New +$2.03M
ZNTL icon
38
Zentalis Pharmaceuticals
ZNTL
$123M
$2.01M 0.66%
100,000
– –
BBIO icon
39
BridgeBio Pharma
BBIO
$9.91B
$1.98M 0.65%
75,000
+33,000
+79% +$870K
ACAD icon
40
Acadia Pharmaceuticals
ACAD
$4.34B
$1.67M 0.55%
+80,000
New +$1.67M
LEGN icon
41
Legend Biotech
LEGN
$6.64B
$1.51M 0.5%
+22,500
New +$1.51M
QURE icon
42
uniQure
QURE
$954M
$1.44M 0.47%
215,000
– –
RCUS icon
43
Arcus Biosciences
RCUS
$1.24B
$1.35M 0.44%
75,000
– –
TVTX icon
44
Travere Therapeutics
TVTX
$1.75B
$1.34M 0.44%
+150,000
New +$1.34M
ARGX icon
45
argenx
ARGX
$44.2B
$1.23M 0.4%
+2,500
New +$1.23M
VTYX icon
46
Ventyx Biosciences
VTYX
$184M
$1.22M 0.4%
+35,000
New +$1.22M
WHWK
47
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$1.21M 0.4%
250,000
– –
KALV icon
48
KalVista Pharmaceuticals
KALV
$713M
$963K 0.32%
+100,000
New +$963K
BMEA icon
49
Biomea Fusion
BMEA
$114M
$894K 0.29%
65,000
-125,000
-66% -$1.72M
ROIV icon
50
Roivant Sciences
ROIV
$8.6B
$748K 0.25%
64,000
– –
1
2
3